journal
https://read.qxmd.com/read/38315537/the-role-of-erythropoietin-to-prevent-red-blood-cell-transfusion-in-a-2018-2020-two-center-cohort-of-preterm-infants
#1
JOURNAL ARTICLE
Noémie Bailly, Roselyne Brat, Geraldine Favrais
BACKGROUND: Treatment with recombinant human erythropoietin (rHu-EPO) modestly prevented packed red blood cell transfusions (pRBCTs) in preterm infants in studies performed several years ago. In France, some neonatal units stopped using rHu-EPO, while others continued. The aim of this study was to explore the role of rHu-EPO in the prevention of pRBCTs in a recent cohort of preterm infants. MATERIALS AND METHODS: Preterm infants who met rHu-EPO indications and were hospitalised between 2018 and 2020 in two neonatal units-one that did not use rHu-EPO and another that did-were eligible...
February 1, 2024: Blood Transfusion
https://read.qxmd.com/read/38315539/inclusion-of-cryoprecipitate-pathogen-reduced-in-the-who-model-lists-of-essential-medicines-for-adults-and-children-a-call-for-action
#2
JOURNAL ARTICLE
Jay S Epstein, Yuyun Maryuningsih, Jean-Claude Faber, W Martin Smid, Thierry Burnouf
No abstract text is available yet for this article.
January 31, 2024: Blood Transfusion
https://read.qxmd.com/read/38315529/a-systematic-review-of-indications-when-and-how-a-military-walking-blood-bank-could-bridge-blood-product-unavailability
#3
REVIEW
Julie Degueldre, Emilie Dessy, France T'Sas, Véronique Deneys
BACKGROUND: Blood supply problems in remote areas are well known. To overcome this shortage, many countries have developed innovative Walking Blood Bank (WBB) protocols. However, no common standards have yet been set for their use and common actions. Given that these procedures involve a certain risk, it would be interesting to analyse the activating criteria that lead to using this unusual protocol. Thus, this review aimed to identify indications for a WBB and the common risk mitigation measures...
January 31, 2024: Blood Transfusion
https://read.qxmd.com/read/38315540/first-investigation-of-rh-gene-polymorphism-in-patients-with-sickle-cell-disease-and-associated-blood-donors-in-cameroon-central-africa
#4
JOURNAL ARTICLE
Jeanne Manga Messina Mbeti, Caroline Bénech, Françoise Ngo Sack, Estelle Wete, Hortense Ngegni Pangetha, Simon Noël Ateba, Jules Tchatchueng, Alexandre Njan Nloga, Yann Fichou
BACKGROUND: Although genetic polymorphism of the RH blood group system is well known in sub-Saharan Africa, national/regional specificities still remain to be described precisely. For the first time in Cameroon, Central Africa, and in order to better characterize the molecular basis driving RH phenotype variability, as well as to identify the main antigens that may be potentially responsible for alloimmunization, we sought 1) to study the RH genes in a cohort of 109 patients with sickle cell disease; 2) to study the same genes in the corresponding donors whose red blood cells (RBCs) were transfused to the patients (108 donors in 98 patients); 3) to predict RH phenotype on the basis of the molecular data and compare the results with serologic testing; and 4) to identify retrospectively patients at risk for alloimmunization...
January 29, 2024: Blood Transfusion
https://read.qxmd.com/read/38315532/noninvasive-fetal-blood-group-antigen-genotyping
#5
REVIEW
Frederik B Clausen, C Ellen van der Schoot
Noninvasive fetal blood group antigen genotyping serves as a diagnostic tool to predict the risk of hemolytic disease of the fetus and newborn in pregnancies of immunized women. In addition, fetal RHD genotyping is used as an antenatal screening to guide targeted use of immunoglobulin prophylaxis in non-immunized RhD negative, pregnant women. Based on testing of cell-free DNA extracted from maternal plasma, these noninvasive assays demonstrate high performance accuracies. Consequently, noninvasive fetal blood group antigen genotyping has become standard care in transfusion medicine...
January 29, 2024: Blood Transfusion
https://read.qxmd.com/read/38315531/natural-history-of-anti-pf4-antibodies-in-patients-with-vaccine-induced-immune-thrombocytopenia-and-thrombosis
#6
JOURNAL ARTICLE
Elena Lotti, Anna M Gori, Martina Berteotti, Angela Rogolino, Francesca Cesari, Daniela Poli, Francesco Vannini, Alessia Bertelli, Betti Giusti, Rossella Marcucci
No abstract text is available yet for this article.
January 29, 2024: Blood Transfusion
https://read.qxmd.com/read/38315530/anti-cd38-monoclonal-antibody-impairs-cd34-mobilization-and-affects-clonogenic-potential-in-multiple-myeloma-patients
#7
JOURNAL ARTICLE
Arianna Zappaterra, Ivan Civettini, Anna Maria Cafro, Laura Pezzetti, Silvia Pierini, Michela Anghilieri, Laura Bellio, Paola Bertazzoni, Giovanni Grillo, Periana Minga, Maria L Pioltelli, Emanuele Ravano, Marianna Sassone, Clara V Viganò, Elisabetta B Volpato, Carlo Gambacorti-Passerini, Silvano Rossini, Roberto Cairoli, Roberto Crocchiolo
BACKGROUND: Induction with daratumumab-based regimens followed by autologous stem cell transplantation is the current standard for newly diagnosed multiple myeloma (NDMM) patients eligible for intensive chemotherapy. However, concerns emerged regarding potential negative effects following daratumumab-based treatment on CD34+ mobilization. We here compared CD34+ mobilization and clonogenic potential between daratumumab and non-daratumumab based therapy without upfront plerixafor administration among patients affected by NDMM...
January 24, 2024: Blood Transfusion
https://read.qxmd.com/read/38315541/red-blood-cell-transfusion-in-patients-undergoing-elective-primary-glioblastoma-resection
#8
JOURNAL ARTICLE
Vanessa Neef, Sven König, Hendrik Becker, Daniel Dubinski, Armin Flinspach, Florian J Raimann, Katharina Weber, Michael W Ronellenfitsch, Juergen Konczalla, Elke Hattingen, Marcus Czabanka, Christian Senft, Kai Zacharowski, Peter Baumgarten
BACKGROUND: Red blood cell (RBC) transfusion in patients undergoing major elective cranial surgery is associated with increased postoperative morbidity and mortality. This study aims to identify the clinical outcome of transfused glioblastoma patients undergoing primary surgical tumor resection and identify risk factors for RBC transfusion. MATERIAL AND METHODS: Between 2009 and 2019, 406 patients underwent elective primary glioblastoma resection. For multivariate analysis to assess risk factors for RBC transfusion, logistic regression was conducted...
January 11, 2024: Blood Transfusion
https://read.qxmd.com/read/38315535/hla-class-i-expression-on-human-platelets-is-highly-variable-and-correlates-with-distinct-allele-group-frequencies
#9
JOURNAL ARTICLE
Rocco Cantisani, Valeria Del Re, Francesca Toraldo, Silvia Cantara, Simone Pozzessere, Giuseppe Marotta, Adriano Spreafico
BACKGROUND: Human leukocyte antigen (HLA) class I molecules are expressed on platelets and can represent a source of alloimmunization in recipients of platelet transfusions. HLA mismatch between donors and recipients may be associated with the induction of anti-HLA antibodies, which can culminate in refractoriness to platelet transfusions. In the present study we analyzed HLA allele group frequencies and HLA expression levels on human platelets from blood donors. MATERIALS AND METHODS: Platelet-rich plasma was collected from 139 donors to monitor platelet HLA class I expression by flow cytometry...
January 11, 2024: Blood Transfusion
https://read.qxmd.com/read/38315533/the-effects-of-pathogen-reduction-technology-on-apheresis-platelet-concentrates-stored-in-pas
#10
JOURNAL ARTICLE
Stavros Tsalas, Andreas G Tsantes, Eleni Petrou, Sofia Mellou, Rozeta Sokou, Electra Loukopoulou, Anastasios G Kriebardis, Sotirios P Fortis, Dimitrios V Papadopoulos, Aristeidis G Vaiopoulos, Styliani Kokoris, Argirios E Tsantes
BACKGROUND: The impact of pathogen reduction technology (PRT) such as Mirasol, and the effect of platelet additive solutions (PAS) on the activity and hemostatic profile of transfused apheresis platelets remain largely unknown. The aim of this study was to assess the in vitro hemostatic and metabolic profile of Mirasol treated platelets in PAS during a 7-day storage period. MATERIAL AND METHODS: Ten split bags containing apheresis platelets stored in PAS were split into two groups; control platelets (No...
January 9, 2024: Blood Transfusion
https://read.qxmd.com/read/38315538/the-72g-a-nucleotide-substitution-impairs-transcription-of-the-abo-gene-via-reduction-of-promoter-activity
#11
JOURNAL ARTICLE
Hang Lei, Jiewei Zheng, Dong Xiang, Hui Zhang, Xuefeng Wang, Xiaohong Cai
No abstract text is available yet for this article.
December 21, 2023: Blood Transfusion
https://read.qxmd.com/read/38315534/evaluation-of-an-automated-platelet-aggregation-method-for-detection-of-congenital-or-acquired-platelet-function-defects
#12
JOURNAL ARTICLE
Anna Lecchi, Marco Capecchi, Lidia Padovan, Andrea Artoni, Nobuo Arai, Sho Shinohara, Silvia La Marca, Flora Peyvandi
BACKGROUND: Light transmission aggregometry (LTA) is the most widely used laboratory method for an initial screening of patients with a suspected platelet function defect (PFD), and its use has also been proposed for assessing the efficacy of antiplatelet treatment (APT). An automated LTA method has been developed by Sysmex (Kobe, Japan) on a routine coagulation analyzer (CS-2400), together with a new research parameter called PAL (platelet aggregation level) to evaluate patients on APT...
December 21, 2023: Blood Transfusion
https://read.qxmd.com/read/38315536/establishment-of-a-case-registry-that-collaborates-with-a-reference-laboratory-for-blood-group-immunogenetics-in-korea
#13
LETTER
Dong Woo Shin, Yun Ji Hong, Kyoung Un Park
No abstract text is available yet for this article.
December 19, 2023: Blood Transfusion
https://read.qxmd.com/read/38063786/extract-from-the-2022-esc-guidelines-on-cardiovascular-assessment-and-management-of-patients-undergoing-non-cardiac-surgery-patient-blood-management
#14
JOURNAL ARTICLE
Sigrun Halvorsen, Julinda Mehilli, Suma Choorapoikayil, Kai Zacharowski
The 2022 Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology are an update on the previous guidelines reported in 2014. The revised guidelines provide standardized perioperative cardiovascular management of surgical patients and emphasis on risk assessment of the patient combined with the inherent risk of the surgical procedure. One of the novelties in these guidelines is the Patient Blood Management programme, which is based on a three pillar concept: preoperative hemoglobin optimization, minimize iatrogenic blood loss and bleeding, and harness tolerance to anemia in an effort to improve patient outcome...
December 6, 2023: Blood Transfusion
https://read.qxmd.com/read/38276913/patient-blood-management-in-obstetrics-a-plea-for-widespread-and-effective-implementation
#15
EDITORIAL
Manuel Muñoz
No abstract text is available yet for this article.
January 2024: Blood Transfusion
https://read.qxmd.com/read/38276912/autologous-transfusion-requirements-in-bone-marrow-harvest-results-of-the-atrema-study
#16
LETTER
Caterina G Valentini, Idanna Innocenti, Claudio Pellegrino, Gaetano Draisci, Luciana Teofili
No abstract text is available yet for this article.
January 2024: Blood Transfusion
https://read.qxmd.com/read/38063790/knowledge-attitudes-and-practices-for-blood-safety-in-a-worldwide-perspective
#17
EDITORIAL
Massimo La Raja
No abstract text is available yet for this article.
November 30, 2023: Blood Transfusion
https://read.qxmd.com/read/38063788/ten-years-of-a-neonatal-screening-program-for-hemoglobinopathies-in-friuli-venezia-giulia-first-regional-experience-in-italy
#18
JOURNAL ARTICLE
Epifania R Testa, Margherita Robazza, Francesca Barbieri, Laura Travan, Maria P Miani, Elisabetta Miorin, Ingrid Toller, Danica Dragovic, Valentina Moretti, Stefano Facchin, Patrizia Valeri, Luciana Geremia, Valeria Brunetta, Roberto Dall'Amico, Andrea Bontadini
BACKGROUND: Hemoglobinopathies are the commonest genetic defect worldwide (7% of the world's population has at least one hemoglobin mutation). Although prenatal screening for hemoglobinopathies is not obligatory during pregnancy in Italy, it is offered to women by the Italian National Health Service in the pre-conception phase. The screening of newborns is a valid alternative, and has been adopted in various European countries, albeit in a piecemeal fashion. Neonatal screening has the advantage of providing early diagnosis of a hemoglobinopathy...
November 30, 2023: Blood Transfusion
https://read.qxmd.com/read/38063785/denv-outbreak-in-italy-the-impact-on-the-national-transfusion-network
#19
LETTER
Ilaria Pati, Giulio Pisani, Flavia Riccardo, Giulietta Venturi, Vincenzo De Angelis
No abstract text is available yet for this article.
November 30, 2023: Blood Transfusion
https://read.qxmd.com/read/38063791/t-tas-%C3%A2-01-as-a-new-tool-for-the-evaluation-of-hemostasis-in-thrombocytopenic-patients-after-platelet-transfusion
#20
JOURNAL ARTICLE
Sahar Samanbar, Juan A Piñeyroa, Ana B Moreno-Castaño, Marc Pino, Sergi Torramadé-Moix, Julia Martinez-Sanchez, Miquel Lozano, Cristina Sanz, Ginés Escolar, Maribel Diaz-Ricart
BACKGROUND: Current laboratory tests fail to evaluate the hemostatic function of platelets in patients with thrombocytopenia. We investigated the use of the Total Thrombus-Formation Analysis System (T-TAS® 01 [Fujimori Kogyo Co, Tokyo, Japan]) to evaluate hemostasis under conditions of experimental thrombocytopenia, and in patients before and after platelet transfusion. MATERIALS AND METHODS: Specific T-TAS 01 chips, for thrombocytopenic conditions, were used...
November 29, 2023: Blood Transfusion
journal
journal
40947
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.